Genmab | Resultat Før Skat



Pre Tax Profit Lave om Dato
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Almirall EUR 15.17M 72K 2024-06
Amarin USD -21529000 24.42M 2024-09
Amgen USD 3.38B 111M 2024-12
argenx SE USD 88.02M 103.02M 2024-09
AstraZeneca USD 1.67B 162M 2024-12
Bayer EUR -481000000 805M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Demant DKK 967M 76M 2024-12
Exelixis USD 184.77M 30.02M 2024-12
Fresenius Medical Care EUR 179.93M 201.07M 2024-12
Galapagos EUR 19.03M 68.17M 2024-12
Genmab DKK 3.6B 1.88B 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
GN Store Nord DKK 21M 350M 2024-12
GRIFOLS EUR 66.98M 38.41M 2024-06
Hikma Pharmaceutical USD 144M 144M 2024-06
Insmed USD -234282000 14.77M 2024-12
Lonza CHF 427M 167M 2024-06
Merck EUR 1.23B 449.38M 2024-09
Novartis USD 4.66B 269M 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
UCB EUR 123M 464.07M 2024-06



Genmab Resultat Før Skat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.